XORTX Therapeutics Inc.(XRTX)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

XORTX Therapeutics Inc. (XRTX) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. XRTX is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of XRTX by reported 13-F value include CITADEL ADVISORS, StoneX Group, ROYAL BANK OF CANADA, based on the most recent SEC filings. XRTX trades on the Nasdaq exchange and files with the SEC under CIK 1729214. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate XRTX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for XORTX Therapeutics Inc. directly from SEC EDGAR.

Institutions holding XRTX

Institutional investors reporting a position in XORTX Therapeutics Inc. on SEC Form 13F.
InstitutionSharesValueReported
CITADEL ADVISORS23,116$52.5K2026-06-30
StoneX Group16,369$37.9K2026-06-30
ROYAL BANK OF CANADA732$2.0K2026-06-30
NATIONAL BANK OF CANADA162$329.002026-06-30
Clearstead Advisors55$120.002026-06-30
TD Waterhouse Canada9$19.002026-06-30
XRTX

XORTX Therapeutics Inc.

XRTX
NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Financial metrics will appear once SEC EDGAR data is ingested for this company.

Top Institutional Holders

as of Q2 2026
$92.8K total
Loading ratio trend…